Introducing the iSeq 100, the latest advancement in the world of next-generation sequencing (NGS) from Illumina. The iSeq 100 instrument leverages Illumina technological advances in its smallest and most accessible system to date. Building on trusted sequencing by synthesis (SBS) chemistry and combining it with the latest single channel complementary metal-oxide-semiconductor (CMOS) detection technology, the iSeq 100 offers researchers an accessible and low-cost benchtop sequencing solution. Get a behind-the-scenes look at the workflow in this demo video.
Subscribe to the Illumina video channel
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015.